Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Key Scientific Issues in Research for Quality Control of Chinese Medicines Read chapter Read first chapter

2024 | OriginalPaper | Chapter

7. Molecular Docking for Virtual Screening of Potential Active Ingredients in Chinese Medicines

Authors : Yuan-yuan Xie, Shu-mei Wang

Published in: Quality Control of Chinese Medicines

Publisher: Springer Nature Singapore

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Traditional Chinese medicine (TCM) plays a vital role in the prevention and treatment of various diseases for thousands of years. It is of great significance to elucidate the effective material basis and related action mechanism for promoting the modernization of TCM, as well as the research and development of innovative Chinese medicine. Virtual screening is also called computer-aided screening, that is, compound molecules are pre-screened on the computer with a suitable algorithm before biological activity screening, in order to reduce the actual number of screened compounds and improve the discovery efficiency of lead compounds. Recently, molecular docking-based virtual screening techniques had been applied for discovering active ingredients in Chinese medicine. This chapter introduces the research strategies and related technologies of molecular docking, including chemoinformatics and bioinformatics, principle and basic protocols of molecular docking, as well as the application of molecular docking in the discovery of active ingredients.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
previous chapter Network Pharmacology to Clarify the Effective Substances and Their Action Mechanisms of Traditional Chinese Medicines
next chapter Knock-Out and Knock-In Technique for Finding Integrative Components that Contribute to Effect of Chinese Medicines
Literature
1.
G. Luo, L. Qionglin, W. Yiming et al., Systems biology for traditional Chinese medicine (John Wiley & Sons Inc., Hoboken, 2012)
2.
G. Luo, W. Yiming, Exploration on Holistic Systemic Medicine. Beijing: Science Press (2020)
3.
S. Li, B. Zhang, N. Zhang, Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biol. 5 (Suppl 1): S10 (2011)
4.
X.J. Wang, Progress and future developing of the serum pharmacochemistry of traditional Chinese medicine. China J Chin Mater Med 31(10), 789–792 (2006)
5.
A. H. Zhang, H. Sun, G. Yan, Y. Han, Q. Zhao, X. Wang, Chinmedomics: A powerful approach integrating metabolomics with serum pharmacochemistry to evaluate the efficacy of traditional Chinese medicine. Engineering, 5: 60–68 (2019)
6.
Z. Liping, Microbiome and Precision Medicine (Shanghai Jiaotong University Press, Shanghai, 2017)
7.
W. Ma, Y. Xie, Y. Wang, G. Luo, Emerging application and reflections of cell membrane chromatography in the quality evaluation of traditional Chinese medicine. Acta Pharmaceutica Sinica. 2017, 52 (12): 1827−1838
8.
Q. Xu, Z. Li, M. Wan, Y. Zhang, D. Li, A. Lu, Research progress on screening technology of active ingredients in traditional Chinese medicine. Drug Evaluation Research, 2021, 44(7): 1541-1547
9.
H. Song, H. Yang, W. Gao, J. Chen, P. Li, A Progress on the Key Technologies for Discovery of Bioactive Compounds from Traditional Chinese Medicines. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 18(7): 1093–1098 (2016)
10.
X. Jiao, X. Jin, Y. Ma, Y., Yang, Y., J. Liu, L. Liang, R. Liu, Z. Liu, A comprehensive application: molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanism of action in component-based Chinese medicine. Comput. Biol. Chem.. Biol. Chem. 90, 107402 (2021)CrossRef
11.
W. Fu, D. Ye, An introduction to computer-aided drug design. Beijing: Chemical Industrial Press (2017)
12.
E. Fischer, Einfluss der configuration auf die wirkung der enzyme. Ber. Dtsch. Chem. Ges.Dtsch. Chem. Ges. 27, 3189–3232 (1894)
13.
14.
L.G. Ferreira, R.N. dos Santos, G. Oliva, A.D. Andricopulo, Molecular Docking and Structure-Based Drug Design Strategies. Molecules 20, 13384–13421 (2015)PubMedPubMedCentralCrossRef
15.
X. Xu, C. Wang, Applications of Molecular Docking: Beyond the Drug Discovery. Journal of Beijing University of Technology. 2017, 43(12): 1872–1880
16.
Y. Elizabeth, A. Mark, P.A. Ramsland, Challenges and advances in computational docking, In review. J. Mol. Recognit.Recognit. 2011(24), 149–164 (2009)
17.
D.K. Agrafiotis, A.C. Gibbs, F. Zhu, S. Izrailev, E. Martin, Conformational sampling of bioactive molecules: A comparative study. J. Chem. Informat. Model. 47: 1067–1086 (2007)
18.
W. Wenjun, D. Yi, X. Dou Fang, J.Y. Hang, F. Xiaona, W. Aidong, Application of Molecular Docking in the Studies on Screening and Mechanism of Pharmacodynamic Substances of Traditional Chinese Medicine. China Pharmacist 21(6), 1020–1023 (2018)
19.
Q. Huijing, D. Ziru, X.U. Ge Guangbo, Y.L. Shaoxian, Applications of molecular docking in drug discovery. J. Nanyang Normal University. 14(12), 29–35 (2015)
20.
W.U. Jian, X. Xiaoyan, W. Lifang, G. Xiaohua, X. Linlin, Application and development of molecular docking methods. Asia-Pacific Traditional Medicine. 9(12), 80–81 (2013)
21.
B.L. Stoddard, D.E. Koshland Jr., Prediction of the structure of a receptor-protein complex using a binary docking method. Nature, 358 (27) : 774–776 (1992)
22.
K. Bernd, R. Matthias, L. Thomas, Evaluation of the FLEXX incremental construction algorithm for pro tein-ligand docking. Proteins Struct. Funct. Genet.Funct. Genet. 37(2), 228–241 (2004)
23.
L. Chen, L. Cheng, M. Zheng, P. Zhang, J. Xie, H. Li, Progress in Structure-based Screening of Active Natural Products. Prog. Pharmaceutical Sci. 42 (1): 39-51 (2018)
24.
R. Giege, A historical perspective on protein crystallization from 1840 to the present day. FEBS J. 280, 6456–6497 (2013)
25.
J. Clarkson, I.D. Campbell, Studies of protein-ligand interactions by NMR. Biochem. Soc. Trans.. Soc. Trans. 31(Pt 5), 1006 (2003)CrossRef
26.
K. Taylor, R.M. Glaeser, Electron microscopy of frozen hydrated biological specimens. Journal of Ultrastructure Research. 1976, 55 (3): 448–456 (1976)
27.
D.P. Allison, N.P. Mortensen, C.J. Sullivan, M.J. Doktycz, Atomic force microscopy of biological samples. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2(6), 618–634 (2010)PubMed
28.
M.T. Muhammed, E. Aki-Yalcin, Homology modeling in drug discovery: Overview, current applications, and future perspectives. Chemical Biology & Drug Design. 93(1):12–20 (2019)
29.
Tareq Hameduh, Yazan Haddad. Vojtech Adam, Zbynek Hege. Homology modeling in the time of collective and artificial intelligence. Computational and Structural Biotechnology Journal, 2020, 18: 3494–3506.
30.
E. Krieger, S.D. Nabuurs, G. Vriend, Structural Bioinformatics, P.E. Bourne, H. Weissig, Ed., Wiley-Liss, 2012, pp. 507–520.
31.
H. Berman, K. Henrick, H. Nakamura, Announcing the worldwide Protein Data Bank. Nat. Struct. Mol. Biol. 10, 980 (2003)CrossRef
32.
Aleix Gimeno, María José Ojeda-Montes, Sarah Tomás-Hernández, Adrià Cereto-Massagué, Raúl Beltrán-Debón, Miquel Mulero, Gerard Pujadas, Santiago Garcia-Vallvé. The Light and Dark Sides of Virtual Screening: What Is There to Know? International Journal of Molecular Sciences. 2019, 20, 1375.
33.
34.
H. Ke, Z. Lei, W. Miao, R. Zhang, W. Chunyu, Z. Chengzhi, Prediciton Methods of Herbal Compounds in Chinese Medicinal Herbs. Molecules 23, 2303 (2018)CrossRef
35.
Shen Jianhua, Xu Xiaoying, Cheng Feng, Liu Hong, Luo Xiaomin, Shen Jingkang, Chen Kaixian, Zhang Weimin, Shen Xu, Jiang Hualiang. Virtual Screening on Natural Products for Discovery Active Compounds and Target Information. Current Medicinal Chemistry, 2003, 10, 2327-2342
36.
Liu Yutian, Zhao Shiyu, Lv Shaowa. Application of virtual screening technology based on molecular docking in drug discovery. Chemical Engineer. 2020, 293(2): 59-63.
37.
Yang Baoyu, Mao Jing, Gao Bing, Lu Xiuli. Computer-Assisted Drug Virtual Screening Based on the Natural Product Databases. Current Pharmaceutical Biotechnology, 2019, 20: 293-301
38.
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018, 46 (Database issue): D1074–D1082.
39.
40.
P. Banerjee, J. Erehman, B.O. Gohlke, T. Wilhelm, R. Preissner, M. Dunkel, Super natural II-a database of natural products. Nucleic Acids Res. 43(D1), D935–D939 (2015)PubMedCrossRef
41.
Tsai, T.Y.; Chang, K.W.; Chen, Y.C. iScreen: World’s first cloudcomputing web server for virtual screening and de novo drug design based on TCM database@Taiwan. J. Comput.-Aided Mol. Design, 2011, 25(6), 525–531.
42.
43.
Xue, R.; Fang, Z.; Zhang, M.; Yi, Z.; Wen, C.; Shi, T. TCMID: Traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res., 2013, 41(Database issue), D1089.
44.
Jinlong Ru, Peng Li, Jinan Wang, Wei Zhou, Bohui Li, Chao Huang, Pidong Li, Zihu Guo, Weiyang Tao, Yinfeng Yang, Xue Xu, Yan Li, Yonghua Wang, Ling Yang. eCollection 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014 Apr 16;6:13. doi: https://​doi.​org/​10.​1186/​1758-2946-6-13.
45.
T. Sterling, J.J. Irwin, ZINC 15 - ligand discovery for everyone. J. Chemic. Inform. Model. 55(11), 2324–2337 (2015)CrossRef
46.
J.H. McKerrow, C.A. Lipinski, The rule of five should not impede anti-parasitic drug development. Int. J. Parasitol. Drugs Drug Resist.Parasitol. Drugs Drug Resist. 7, 248–249 (2017)CrossRef
47.
A. Daina, O. Michielin, V. Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017)PubMedPubMedCentralCrossRef
48.
Feixiong Cheng, Weihua Li, Yadi Zhou, Jie Shen, Zengrui Wu, Guixia Liu, Philip W Lee, Yun Tang. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012, 52(11): 3099–105.
49.
Hongbin Yang, Chaofeng Lou, Lixia Sun, Jie Li, Yingchun Cai, Zhuang Wang, Weihua Li, Guixia Liu, Yun Tang. admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019, 35(6): 1067–1069.
50.
Chen R. Li L., Weng Z. ZDOCK: an initial-stageprotein-docking algorithm. Proteins: Structure, Function, and Bioinformatics. 2003, 52(1): 80–87.
51.
Ritchie D. W., Kemp G. J. Protein docking using spherical polar Fourier correlations. Proteins: Structure, Function, and Bioinformatics. 2000, 39(2): 178–194.
52.
José Ignacio Garzon, José Ramón Lopéz-Blanco, Carles Pons, Julio Kovacs, Ruben Abagyan, Juan Fernandez-Recio, Pablo Chacon. FRODOCK: a new approach for fast rotational protein-protein docking. Bioinformatics, 2009, 25(19): 2544–2551.
53.
J.H. Holland, Adaptation in natural and artificial system (University of Michigan Press, Ann Arbor, 1975), pp.1–183
54.
N. Metropolis, A.W. Rosenbluth, M.N. Rosenbluth et al., Equations of state calculations by fast computing machines. J. Chem. Phys. 21(6), 1087–1092 (1953)CrossRef
55.
Morris G.M., Goodsell D.S., Huey R., Olson A.J. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des. 1996, 10, 293–304.
56.
G. Jones, P. Willett, R.C. Glen, A.R. Leach, R. Taylor, Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267, 727–748 (1997)PubMedCrossRef
57.
E.M. Krovat, T. Steindl, T. Langer, Recent advances in docking and scoring. Curr. Comput. Aided Drug Des.Comput. Aided Drug Des. 1, 93–102 (2005)CrossRef
58.
G. Junichi, K. Ryoichi, M. Hajime, H. Noriaki, ASEDock - docking based on alpha spheres and excluded volumes. J. Chem. Inf. Model. 48(3), 583–590 (2008)CrossRef
59.
O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem.Comput. Chem. 31, 455–461 (2010)CrossRef
60.
Jessica K Gagnon, Sean M Law, Charles L Brooks 3rd. Flexible CDOCKER: Development and application of a pseudo-explicit structure-based docking method within CHARMM. J Comput Chem. 2016, 37(8):753–762
61.
Ewing T.J., Makino S., Skillman A.G., Kuntz I.D. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 2001, 15: 411–428.
62.
Zhu Zhendong, Hu Zenjian, Rong Soubao, Enyedy Istvan J., Wang Shaomeng. Systematic investigations of flexible ligand docking methods. Abstracts of Papers, 220th ACS National Meeting, Washington, DC, United States, August 20–24, 2000 (2000), COMP-099.
63.
A. Grosdidier, V. Zoete, O. Michielin, EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins 67(4), 1010–1025 (2007)PubMedCrossRef
64.
Zsolt Zsoldos, Darryl Reid, Aniko Simon, Sayyed Bashir Sadjad, A Peter Johnson. eHiTS: a new fast, exhaustive flexible ligand docking system. J Mol Graph Model. 2007, 26(1):198–212.
65.
B. Kramer, M. Rarey, T. Lengauer, Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 37(2), 228–241 (1999)PubMedCrossRef
66.
Zhao Yong, Sanner Michel F. FLIPDock: docking flexible ligands into flexible receptors. Proteins: Structure, Function, and Bioinformatics,2017, 68(3), 726–737.
67.
M.D. Miller, S.K. Kearsley, D.J. Underwood, R.P. Sheridan, FLOG: a system to select ‘quasi-flexible’ ligands complementary to a receptor of known three- dimensional structure. J. Comput. Aided Mol. Des.Comput. Aided Mol. Des. 8(2), 153–174 (1994)CrossRef
68.
McGann Mark, FRED Pose Prediction and Virtual Screening Accuracy. J. Chem. Inf. Model. 51(3), 578–596 (2011)CrossRef
69.
Welch William, Ruppert Jim, Jain Ajay N. Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. Chemistry & Biology. 1996, 3(6): 449–462.
70.
Friesner Richard A., Banks Jay L., Murphy Robert B., Halgren Thomas A., Klicic Jasna J., Mainz Daniel T., Repasky Matthew P., Knoll Eric H., Shelley Mee, Perry Jason K., et al. Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. Journal of Medicinal Chemistry. 2004, 47(7): 1739–1749.
71.
A. Ruben, T. Maxim, K. Dmitry, ICM-a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem.Comput. Chem. 15(5), 488–506 (1994)CrossRef
72.
B. Gorelik, A. Goldblum, High quality binding modes in docking ligands to proteins. Proteins 71(3), 1373–1386 (2008)PubMedCrossRef
73.
C.M. Venkatachalam, X. Jiang, T. Oldfield, M. Waldman, LigandFit: a novel method for the shape-​directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model. 21(4), 289–307 (2003)PubMedCrossRef
74.
A.N. Jain, Surflex: Fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 46, 499–511 (2003)PubMedCrossRef
75.
Schnecke Volker, Kuhn Leslie A. Lengauer Thomas. Database screening for HIV protease ligands: the influence of binding-​site conformation and representation on ligand selectivity. Proceedings-International Conference on Intelligent Systems for Molecular Biology, 7th, Heidelberg, Germany, Aug. 6–10, 1999 (1999), 242–251.
76.
He Qingxiu, Chen Xin, Yang Xi, Li Guangpin, Guo Haiqiong, Chu Han, Lin Zhihua, Wang Yuanqiang. Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro). Letters in Drug Design & Discovery. 2021, 18(4): 355-364
77.
Li Lingyu, Ma Liyan, Hu Yue, Li Xiaoxue, Yu Meng, Shang Hai, Zou Zhongmei. Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease. Phytochemistry (Elsevier). 2022, 193: 112984
78.
Abel Renata, Ramos Maria Paredes, Chen Qiaofeng, Perez-Sanchez Horacio, Coluzzi Flaminia, Rocco Monica, Marchetti Paolo, Mura Cameron, Simmaco Maurizio, Bourne Philip E., et al. Computational prediction of potential inhibitors of the main protease of SARS-CoV-2. Frontiers in Chemistry (Lausanne, Switzerland). 2020, 8, 590263.
79.
H. Wu, J. Wang, Y. Yang, T. Li, Y. Cao, Y. Qu, Y. Jin, C. Zhang, Y. Sun, Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Acta Pharm. Sin. B. 55, 374–383 (2020)
80.
Y. Yao, Z. He, X. Liu, Y. He, Y. Lei, S. Zhang, L. Zhao, T. Liu, Potential material basis of Kangbingdu Keli for the treatment of coronavirus pneumonia 2019 (COVID-2019) based on network pharmacology and molecular docking technology. Chinese Traditional and Herbal Drugs 51(06), 1386–1396 (2020)
81.
J. Zhao, S.S. Tian, D. Liu et al., Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19. Phytomedicine 85, 153315 (2021)PubMedCrossRef
82.
Ren Xia, Shao Xin-Xin, Li Xiu-Xue, Jia Xin-Hua, Song Tao, Zhou Wu-Yi, Wang Peng, Li Yang, Wang XiaoLong, Cui Qing-Hua, et al. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. Journal of Ethnopharmacology. 2020, 258: 112932
83.
Chen Peng-yu, Wang Chen, Zhang Ying, Yuan Chong, Yu Bing, Ke Xin-ge, Wu He-zhen, Yang Yan-fang, Xiao Xue-cheng. Predicting the Molecular Mechanism of “Angong Niuhuang Pills” in the Treatment of COVID-19 Based on Network Pharmacology. Natural Product Communications, 2021, 16(6): 1934578X211024032.
84.
Li Yatong, Zhang Yuxin, Wu Xia, Gao Yanbin, Guo Junfang, Tian Yulang, Lin Ziyue, Wang Xing. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies. Bioorganic Chemistry. 2021, 115: 105197
85.
Yang Zhen, Lu Zhi-Qiang, Zhang Yan-Jun, Li Yu-Bo, Wang Zeng-Yong, Zhang Yan-Ling, Zhuang Peng-Wei, Bai Gang. Looking for agonists of β2 adrenergic receptor from Fuzi and Chuanwu by virtual screening and dual- luciferase reporter assay. Journal of Asian Natural Products Research. 2016, 18(6): 550-561.
86.
Dhanabalan Anantha Krishnan, Subaraja Mamangam, Palanichamy Kuppusamy, Velmurugan Devadasan, Gunasekaran Krishnasamy. dentification of a Chlorogenic Ester as a Monoamine Oxidase (MAO-B) Inhibitor by Integrating “Traditional and Machine Learning” Virtual Screening and In Vitro as well as In Vivo Validation: A Lead against Neurodegenerative Disorders? ACS Chemical Neuroscience. 2021, 12(19): 3690–3707.
87.
C.R. Wu, M.Z. Zheng, S.Y. Gao et al., A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent antitumor activity. Oncotarget 8(69), 113516–113530 (2017)PubMedPubMedCentralCrossRef
88.
Y. Gao, L.H. Zhu, J. Guo et al., Farnesylphenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense. Oncotarget 26, 3556–3561 (2017)
89.
He Yan, Zheng Mengzhu, Li Qin, Hu Zhengxi, Zhu Hucheng, Liu Junjun, Wang Jianping, Xue Yongbo, Li Hua, Zhang Yonghui. Asperspiropene A, a novel fungal metabolite as an inhibitor of cancer-associated mutant isocitrate dehydrogenase 1. Organic Chemistry Frontiers (2017), 4(6), 1137-1144.
90.
T. Hsin-Chieh, C. Yu-Chian, Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma. Int. J. Nanomed.Nanomed. 10, 3131–3146 (2015)
91.
Wang Xing, Guo Junfang, Ning Zhongqi, Wu Xia. Discovery of a natural syk inhibitor from chinese medicine through a docking-based virtual screening and biological assay study. Molecules. 2018, 23(12), 3114/1–3114/11.
92.
Guo Jun-Fang, Ning Zhong-Qi, Wu Xia, Qiao Yan-Jiang, Wang Xing. Discovery of a natural PI3Kd inhibitor through virtual screening and biological assay study. Biochemical and Biophysical Research Communications. 2019, 508(3): 709-714
93.
W. Yi-Zhen, M. Lei, Z. Qi-Shuai, S. Liang, Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer’s Disease and Type 2. J. Alzheimers Dis.Alzheimers Dis. 80(2), 787–797 (2021)CrossRef
94.
J. Yingying, G. Hongwei, Pharmacophore-based drug design for potential AChE inhibitors from Traditional Chinese Medicine. Bioorg. Chem.. Chem. 76, 400–414 (2018)CrossRef
95.
Huang Hung-Jin, Chen Hsin-Yi, Lee Cheng-Chun, Chen Calvin Yu-Chian. Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. BioMed Research International. 2014, 452625/1–452625/14, 14 pp.
96.
Wang Hai Qiao, Liu Min, Wang Liang, Lan Fen, Zhang Yi-Han, Xia Jin-Er, Xu Zhen-Dong, Zhang Hai. Identification of a novel BACE1 inhibitor, timosaponin A-III, for treatment of Alzheimer's disease by a cell extraction and chemogenomics target knowledgebase-guided method. Phytomedicine. 2020, 75: 153244.
97.
Huang Hung-Jin, Lee Cheng-Chun, Chen Calvin Yu-Chian. Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. BioMed research international. 2014, 2014764946.
98.
Lin Shih-Hung, Weng Ching-Feng, Shiuan David, Huang Kao-Jean. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structurebased virtual screening. Drug design, development and therapy. 2015, 93313–24.
99.
S. Paoletta, G.B. Steventon, D. Wildeboer, T.M. Ehrman, P.J. Hylands, D.J. Barlow, Screening of herbal constituents for aromatase inhibitory activity. Bioorg. Med. Chem.. Med. Chem. 16(18), 8466–8470 (2008)CrossRef
100.
Wang Wei, Wan Minghui, Liao Dongjiang, Peng Guilin, Xu Xin, Yin Weiqiang, Guo Guixin, Jiang Funeng, Zhong Weide, He Jianxing. Identification of potent chloride intracellular channel protein 1 inhibitors from Traditional Chinese Medicine through structure-based virtual screening and molecular dynamics analysis. BioMed Research International. 2017, 4751780/1–4751780/10.
101.
Rocca Roberta, Moraca Federica, Costa Giosue, et al.Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and cmyc DNA G- quadruplex conformations. Molecules. 2015, 20(1): 206–223/1- 206–223/18, 18 pp.
102.
W. Zhihua, K. Unchol, L. Jinbiao et al., Comprehensive TCM molecular networking based on MS/MS in silico spectra with integration of virtual screening and affinity MS screening for discovering functional ligands from natural herbs. Anal. Bioanal. Chem.Bioanal. Chem. 411(22), 5785–5797 (2019)CrossRef
103.
S. Mao-Feng, Y. Shun-Chieh, C. Kai-Wei et al., Screening from TCM Database Taiwan and QSAR model for identifying HER2 inhibitors. Mol. Simul. 37(10), 884–892 (2011)CrossRef
104.
C. Tung-Ti, S. Mao-Feng, C. Kuan-Chung et al., Drug discovery for DNA break repair system by screening from TCM database and molecular dynamics approach. Mol. Simul. 37(9), 804–811 (2011)CrossRef
105.
Malami Ibrahim, Bunza Aisha Muktar, Alhassan Alhassan Muhammad, et al. Dihydroartemisinin as a potential drug candidate for cancer therapy: a structural-based virtual screening for multitarget profiling. Journal of Biomolecular Structure and Dynamics. 2022, 40(3): 1347–1362.
106.
Lu Fang, Luo Ganggang, Qiao Liansheng, et al. Virtual screening for potential allosteric inhibitors of cyclin-dependent kinase 2 from traditional Chinese medicine. Molecules. 2016, 21(9): 1259/1–1259/14.
107.
Chen Kuan-Chung, Lee Wen-Yuan, Chen Hsin-Yi, Chen, Calvin Yu-Chian. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers. BioMed Research International. 2014, 429486/1- 429486/14.
108.
Cui Herong, Yang Xuexin, Wang Zhidong, et al. Tetrahydropalmatine triggers angiogenesis via regulation of arginine biosynthesis. Pharmacological Research. 2021, 163: 105242
109.
Zou Jia, Chen Yang, Li Jun, et al. Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen (Salvia miltiorrhiza). Evidence-based complementary and alternative medicine : eCAM. 2018, 20189387568.
110.
Jiang Ludi, He Yusu, Luo Ganggang, et al. Discovery of potential novel microsomal triglyceride transfer protein inhibitors via virtual screening of pharmacophore modelling and molecular docking. Molecular Simulation. 2016, 42(15): 1223-1232.
111.
Wang Xing, Wu Xia, Fan Hantian, et al. Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies. Scientific reports. 2017, 744040.
112.
C. Kuan-Chung, C. Su-Sen, H. Hung-Jin et al., Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. J. Biomol. Struct. Dyn.Biomol. Struct. Dyn. 30(6), 662–683 (2012)CrossRef
113.
H. Xiaoqian, Q. Liansheng, C. Yankun et al., Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine. Sci. Rep. 9(1), 16205 (2019)CrossRef
114.
Chen Kuen-Bao, Chen Kuan-Chung, Chang Ya-Lin, et al. In silico investigation of traditional chinese medicine for potential lead compounds as SPG7 inhibitors against coronary artery disease. Molecules, 2016, 21(5): 588/1–588/18.
115.
A. Shahid, L. Dongming, W. Yonghua et al., Identification and Evaluation of Inhibitors of Lipase from Malassezia restricta using Virtual High-Throughput Screening and Molecular Dynamics Studies. Int. J. Mol. Sci. 20(4), 884 (2019)CrossRef
116.
L. Rui, L. Jing, W. Shuqing et al., Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death. Cell Death Dis. 10(7), 1–14 (2019)
117.
Chang Su-Sen, Huang Hung-Jin, Chen Calvin Yu-Chian. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Molecular BioSystems. 2011, 7(12): 3366–3374.
118.
T. Yung-An, C. Kuan-Chung, L. Hung-Che et al., Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS ONE 7(11), e50087 (2012)CrossRef
119.
Selim Nabil Mohamed, Hefnawy Hala Mohamed El, Elgazar Abdullah Abdurrahman, et al. Chrysophanol, Physcion, Hesperidin and Curcumin Modulate the Gene Expression of Pro-Inflammatory Mediators Induced by LPS in HepG2: In Silico and Molecular Studies. Antioxidants (Basel, Switzerland) (2019), 8(9): 371.
120.
Ma Shi-Kun, Wu Ke-Zhu, Li Ai-Xiu. Virtual screening for natural product inhibitors of HIV-1 integrase. Interdisciplinary Sciences: Computational Life Sciences. 2011, 3(1): 17-2
121.
Zhang Zihao, Qiao Yu, Yang Li, et al. Kaempferol 3-O-gentiobioside, an ALK5 inhibitor, affects the proliferation, migration, and invasion of tumor cells via blockade of the TGF-β/ ALK5 /Smad signaling pathway. Phytotherapy Research. 2021, 35(11): 6310-6323
122.
Huo Xiaoqian, Lu Fang, Qiao Liansheng, Li Gongyu, Zhang Yanling. A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network. Evidence-based complementary and alternative medicine: eCAM. 2018, 20181854972.
123.
Chen Xi, Lu Fang, Luo Ganggang, et al.Discovery of selective farnesoid X receptor agonists for the treatment of hyperlipidemia from traditional Chinese medicine based on virtual screening and in vitro validation. Journal of Biomolecular Structure and Dynamics. 2020, 38(15): 4461-4470
124.
Chen Yankun, Chen Xi, Luo Ganggang, et al. Discovery of potential inhibitors of squalene synthase from traditional chinese medicine based on virtual screening and in vitro evaluation of lipid-lowering effect. Molecules. 2018, 23(5): 1040/1–1040/18.
125.
Qiao Liansheng, Li Bin, Chen Yankun, et al. Discovery of anti-hypertensive oligopeptides from adlay based on in silico proteolysis and virtual screening. International Journal of Molecular Sciences. 2016, 17(12): 2099/1–2099/16.
126.
L. Danling, Y. Tianqiao, D. Xue et al., Hypouricaemic and nephroprotective effects of Poria cocos in hyperuricemic mice by up-regulating ATPbinding cassette super-family G member 2. Pharmaceutical Biology (Abingdon, United Kingdom). 59(1), 275–286 (2021)
127.
Yong Tianqiao, Chen Shaodan, Xie Yizhen, et al. Hypouricemic Effects of Extracts From Agrocybe aegerita on Hyperuricemia Mice and Virtual Prediction of Bioactives by Molecular Docking. Frontiers in pharmacology, 2018, 9498.
128.
Bharadwaj Shiv, Lee Kyung Eun, Dwivedi Vivek Dhar, et al. Computational aided mechanistic understanding of Camellia sinensis bioactive compounds against cochaperone p23 as potential anticancer agent. Journal of Cellular Biochemistry. 2019, 120(11): 19064–19075.
129.
W. Xing, G. Junfang, N. Zhongqi et al., Discovery of a Natural Syk Inhibitor from Chinese Medicine through a Docking-Based Virtual Screening and Biological Assay Study. Molecules (Basel, Switzerland). 23(12), 3114 (2018)CrossRef
130.
Chen Kuan-Chung, Chen Calvin Yu-Chian. Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter. 2011, 7(8):4001–4008.
131.
H. Hung-Jin, C. Hsin-Yi, C. Yuan-Shiun et al., Insight into two antioxidants binding to the catalase NADPH binding site from traditional Chinese medicines. RSC Adv. 5(9), 6625–6635 (2015)CrossRef
132.
Karthick Vasudevan, Ramanathan Karuppasamy. Virtual screening for oseltamivir-resistant a (H5N1) influenza neuraminidase from traditional Chinese medicine database: a combined molecular docking with molecular dynamics approach. SpringerPlus. 2013, 2(1):115/1–115/10, 10.
133.
Chen Hsin-Yi, Chang Su-sen, Chan Yueh-Chiu, Chen Calvin Yu-Chian. Discovery of novel insomnia leads from screening traditional Chinese medicine database. Journal of Biomolecular Structure and Dynamics. 2014, 32(5): 776–791.
134.
Chen Kuan-Chung, Lee Wen-Yuan, Chen Hsin-Yi, Chen Calvin Yu-Chian. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. BioMed Research International, 2014, 139492/1–139492/10, 10 pp..
135.
Y.-L. Chang, H.-Y. Chen, K.-B. Chen et al., Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine. SAR QSAR Environ. Res. 27(7), 589–608 (2016)PubMedCrossRef
136.
Li Binbin, He Zhiwei, Xu Nansong, et al. Isobavachalcone exerts anti-proliferative and pro-apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway. Oncology reports. 2019, 41(6): 3355-3366
137.
Su Wei, Liao Minru, Tan Huidan, Chen Yanmei, Zhao Rongyan, Jin Wenke, Zhu Shiou, Zhang Yiwen, He Li, Liu Bo. Identification of autophagic target RAB13 with small-molecule inhibitor in low-grade glioma via integrated multi-omics approaches coupled with virtual screening of traditional Chinese medicine databases. Cell Proliferation. 2021, 54(12): e13135
138.
Arya Hemant, Coumar Mohane Selvaraj. Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase. Journal of Molecular Modeling, 2014, 20(6): 1–13.
139.
Cui Lu, Wang Yu, Liu Zhihong, et al. Discovering New Acetylcholinesterase Inhibitors by Mining the Buzhongyiqi Decoction Recipe Data. Journal of Chemical Information and Modeling. 2015, 55(11): 2455-2463
140.
F. Han-Tian, G. Jun-Fang, Z. Yu-Xin et al., The rational search for PDE10A inhibitors from Sophora flavescens roots using pharmacophore- and docking-based virtual screening. Mol. Med. Rep. 17(1), 388–393 (2018)
141.
J. Ludi, Z. Xianbao, C. Xi et al., Virtual screening and molecular dynamics study of potential negative allosteric modulators of mGluR1 from Chinese herbs. Molecules 20(7), 12769–12786 (2015)CrossRef
142.
Kumar Anish, Ramanathan K. Virtual screening approach to identify potential ALK inhibitor from traditional Chinese medicine database. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2015, 6(1): 94–101/1- 94–101/8, 8 pp..
143.
Zhao Guo-Fang, Huang Zuo-An, Du Xue-Kui, et al. Molecular docking studies of Traditional Chinese Medicinal compounds against known protein targets to treat non-small cell lung carcinomas. Molecular Medicine Reports. 2016, 14(2):1132-1138
144.
Z. Fu-Li, Y. Guang-Hua, X. Sen et al., In silico analysis of the effect of mutation on epidermal growth factor receptor in non-small-cell lung carcinoma: from mutational analysis to drug designing. J. Biomol. Struct. Dyn.Biomol. Struct. Dyn. 35(2), 427–434 (2017)CrossRef
145.
Kikiowo Babatomiwa, Ogunleye Joseph A., Metibemu Damilohun S., Omotuyi Olaposi I., Adelakun, Niyi S. Virtual screening and pharmacokinetic studies of potential MAO-B inhibitors from traditional chinese medicine. Journal of Biological Engineering Research and Review. 2020, 7(1): 8–15.
146.
T. Hsin-Chieh, C. Yu-Chian, Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation. Springerplus 4(1), 1–18 (2015)
147.
X. Liu, Y. Wu, R.C. Stevens et al., Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors. Scientif. Rep. 8(1): 8084 (2018)
148.
W.Y. Lee, H.Y. Chen, K.C. Chen, Chen Calvin Yu-Chian. Treatment of rheumatoid arthritis with traditional chinese medicine. BioMed Res Int. 2014528018 (2014)
149.
C. Sathishkumar, S. Gurudeeban, S. Chandrabose et al., Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2). Int. J. Biol. Macromol.Macromol. 144, 53–66 (2020)CrossRef
150.
L. Li, Z. Qianqian, H. Zhixiang et al., The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase. Comb. Chem. High Throughput Screening 21(4), 292–297 (2018)CrossRef
151.
K.C. Chen, Y.C. Chen, Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 7(8): 4001–4008 (2011)
152.
V. Karthick, N. Nagasundaram, C.G.P. Doss, et al. Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus. Infectious diseases of poverty, 5:12 (2016)
153.
Z. Liu, J. Zhao, W. Li, et al. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Scientific Reports 6 19095 (2016)
154.
U. Grienke, J. Mihaly-Bison, D. Schuster, et al., Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum. Bioorganic Med. Chem. 19(22): 6779–6791 (2021)
155.
Y. Ma, X. Du, D. Zhao, et al. 18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice. Biochem. Biophys. Res. Commun. 579168–174 (2021)
156.
J. Chao, W. Li, S. Jiajia et al., Screening and identifying of α-amylase inhibitors from medicine food homology plants: Insights from computational analysis and experimental studies. J. Food Biochem.Biochem. 44(12), e13536 (2020)
157.
W. Yong-Lin, Y. Zhuang, Y. Tong et al., Exploring the Hypoglycaemic Mechanism of Chinese Medicine Xiao-Ke-An Based on Target Dipeptidyl Peptidase 4 Using Molecular Docking and Dynamics Simulation. ChemistrySelect 6(31), 8016–8025 (2021)CrossRef
158.
D. Hua, W. Luo, J. Duan et al., Screening and identification of potent α-glycosidase inhibitors from Gardenia jasminoides Ellis. S. Afr. J. Bot. 119, 377–382 (2018)CrossRef
159.
H.C. Tang, Y.C. Chen Calvin, Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine. Evidence-based complementary and alternative medicine: eCAM, 2014385120 (2014)
160.
C. Zhang, T. Su, D. Yu, F. Wang, C. Yue, H.Q. Wang, Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy. J. Ethnopharmacol. 260: 113051 (2021)
161.
H. Ting, D. Zhong-Hua, L. Fei, L. Yu-Tian, Y. Mao-Hua, J. Gui-Hua, Identification of key bioactive anti-migraine constituents of Asari radix et rhizoma using network pharmacology and nitroglycerin-induced migraine rat model. Trop. J. Pharm. Res. 20(5), 987–994 (2021)
162.
Tang Hsin-Chieh, Huang Hung-Jin, Lee Cheng-Chun, Chen Calvin Yu Chian. Network pharmacology-based approach of novel traditional Chinese medicine formula for treatment of acute skin inflammation in silico. Computat. Biol. Chem. 71: 70-81 (2017)
163.
W. Nan, H. Shengli, L. Rui, M. Liesu et al., Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus. Phytomedicine 79, 153333 (2020)
164.
Y. Shi, W. Sun, X. Pan, X. Hou, S. Wang, J. Zhang, Establishment of thrombin affinity column (TAC)-HPLC-MS/MS method for screening direct thrombin inhibitors from Radix Salviae Miltiorrhiae. J. Chromatogr. BChromatogr. B 1139, 121894 (2020)
165.
X. Chen, Y. Cao, H. Zhang, Z. Zhu, M. Liu, H. Liu, X. Ding, Z. Hong, W. Li, D. Lv, et al., Comparative Normal/Failing Rat Myocardium Cell Membrane Chromatographic Analysis System for Screening Specific Components That Counteract Doxorubicin-Induced Heart Failure from Acontium carmichaeli. Analytical Chemistry (Washington, DC, United States). 2014, 86(10): 4748-4757.
166.
S.Q. Wu, H.P. Song, L. Bin, R.Z. Liu, H. Yang, L. He, P. Li, A fast and accurate method for the identification of peroxidase inhibitors from Radix Salvia Miltiorrhizae by on-flow biochemical assay coupled with LC/QTOF-MS: comparison with ultrafiltration-based affinity selection. Anal. Bioanal. Chem. 410: 4311-4322 (2018)
167.
Z. Wang, U. Kim, Y. Jiao, C. Li, Y. Guo, X. Ma, M. Jiang, Z. Jiang, Y. Hou, G. Bai, Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects. J. Proteome Res. 18(5): 2100-2108 (2019)
168.
X. Chen, Y. Wu, C. Chen, Y. Yanqiu, et al., Identification potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharamceutica Sinica B. 11(1): 222-236 (2021)
169.
C. Liu, X. Zhu, Y. Lu, X. Zhang, X. Jia, X. Zhang, T. Tai, Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2. J. Pharmaceutical Anal. 11(3): 272-277 (2021)
Metadata
Title
Molecular Docking for Virtual Screening of Potential Active Ingredients in Chinese Medicines
Authors
Yuan-yuan Xie
Shu-mei Wang
Copyright Year
2024
Publisher
Springer Nature Singapore
Book
Quality Control of Chinese Medicines

Print ISBN: 978-981-9998-70-8

Electronic ISBN: 978-981-9998-71-5

Copyright Year: 2024

DOI
https://doi.org/10.1007/978-981-99-9871-5_7

Premium Partners

    Image Credits